estriol has been researched along with Infant, Small for Gestational Age in 42 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
Infant, Small for Gestational Age: An infant having a birth weight lower than expected for its gestational age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the association between a low unconjugated estriol (uE3) in the second trimester and adverse pregnancy outcomes." | 7.70 | Association of low unconjugated estriol in the second trimester and adverse pregnancy outcome. ( Cabaniss, ML; Cusmano, L; Kowalczyk, TD, 1998) |
| " To assess the validity of this assumption, we performed analyses of the association between estriol levels in 188 women in the 17th, 25th, 33rd, and 37th weeks of pregnancy and the birth weights of their infants." | 7.70 | Maternal pregnancy estriol levels in relation to anamnestic and fetal anthropometric data. ( Cnattingius, S; Ekbom, A; Granath, F; Jacobsen, G; Kaijser, M, 2000) |
| "The incidence of major fetal malformations was increased in stillborn infants (14." | 5.26 | Congenital malformations, abnormal glucose tolerance, and estriol excretion in pregnancy. ( Abell, DA; Beischer, NA; Drew, JH, 1978) |
| "To identify the relationship between quadruple test for aneuploidy screening (alpha-fetoprotein: AFP; free beta-human chorionic gonadotropin: b-hCG; unconjugated estriol: uE3 and inhibin-A: IHA) and fetal growth restriction and to construct predictive models for small-for-gestational-age (SGA) fetuses." | 3.96 | Quad test for fetal aneuploidy screening as a predictor of small-for-gestational age fetuses: a population-based study. ( Boonpiam, R; Sekararithi, R; Sirichotiyakul, S; Tongsong, T; Traisrisilp, K; Wanapirak, C, 2020) |
| "To investigate the association between a low unconjugated estriol (uE3) in the second trimester and adverse pregnancy outcomes." | 3.70 | Association of low unconjugated estriol in the second trimester and adverse pregnancy outcome. ( Cabaniss, ML; Cusmano, L; Kowalczyk, TD, 1998) |
| " To assess the validity of this assumption, we performed analyses of the association between estriol levels in 188 women in the 17th, 25th, 33rd, and 37th weeks of pregnancy and the birth weights of their infants." | 3.70 | Maternal pregnancy estriol levels in relation to anamnestic and fetal anthropometric data. ( Cnattingius, S; Ekbom, A; Granath, F; Jacobsen, G; Kaijser, M, 2000) |
| "There were no significant correlations between birthweight ratio (ratio of birthweight to mean weight for gestational age) and hCG, but between birthweight ratio on one hand and estriol for all stages of pregnancy (r = 0." | 3.69 | Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol. ( Aakvaag, A; Bakketeig, LS; Bergsjø, P; Hoffman, HJ; Jacobsen, G; Lie, RT; Markestad, T, 1997) |
| "In an unselected obstetric population of 869 women serial determinations of estriol in serum and urine were performed from the 28th week of pregnancy until delivery." | 3.67 | Estrogen screening in evaluation of fetal outcome and infant's development. ( Fitzer, C; Gerhard, I; Klinga, K; Rahman, N; Runnebaum, B, 1986) |
| "The progressive rise in pregnancy of oestriol values and their significance in assessing fetal viability is well known, although the exact function of this increase is not understood." | 3.66 | Comparison of oestriol in mother and fetus during labour and in the baby at birth. ( Macrae, DJ; Shackleton, CH; Willmott, MP, 1978) |
| "A total of 440 women who had low oestriol excretion in a previous pregnancy was investigated by urinary oestriol assays in one or more subsequent pregnancies." | 3.66 | The recurrence rate and significance of low oestriol excretion in successive pregnancies. ( Beischer, NA; Oats, JJ, 1979) |
| "We investigated if intrauterine growth retardation in these patients could be detected either by the biochemical measurements of by clinical examination." | 1.26 | The use of human placental lactogen, oxytocinase and estriol in twin pregnancies with intrauterine growth retardation. ( Briët, JW; Hoorn, RK, 1982) |
| "Fetal death is unlikely to occur until rate falls below 10 movements/12 hours whilst a rate of less than 21 movements/12 hours is strongly associated with a small-to-dates fetus and indicates the necessity for further assessment of placental function." | 1.26 | Fetal movements in small-for-dates babies. ( Jarvis, GJ; MacDonald, HN, 1979) |
| "The incidence of major fetal malformations was increased in stillborn infants (14." | 1.26 | Congenital malformations, abnormal glucose tolerance, and estriol excretion in pregnancy. ( Abell, DA; Beischer, NA; Drew, JH, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 32 (76.19) | 18.7374 |
| 1990's | 3 (7.14) | 18.2507 |
| 2000's | 2 (4.76) | 29.6817 |
| 2010's | 3 (7.14) | 24.3611 |
| 2020's | 2 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, YR | 1 |
| Kim, N | 1 |
| Ahn, EH | 1 |
| Jung, SH | 1 |
| Park, G | 1 |
| Jung, I | 1 |
| Cho, HY | 1 |
| Boonpiam, R | 1 |
| Wanapirak, C | 1 |
| Sirichotiyakul, S | 1 |
| Sekararithi, R | 1 |
| Traisrisilp, K | 1 |
| Tongsong, T | 1 |
| Güdücü, N | 1 |
| Gönenç, G | 1 |
| Işçi, H | 1 |
| Yiğiter, AB | 1 |
| Dünder, I | 1 |
| Critchfield, AS | 1 |
| Paulus, JK | 1 |
| Farez, R | 1 |
| Urato, AC | 1 |
| Hui, D | 1 |
| Okun, N | 1 |
| Murphy, K | 1 |
| Kingdom, J | 1 |
| Uleryk, E | 1 |
| Shah, PS | 1 |
| Chitayat, D | 1 |
| Farrell, SA | 1 |
| Huang, T | 1 |
| Meier, C | 1 |
| Wyatt, PR | 1 |
| Summers, AM | 1 |
| Khakoo, H | 1 |
| Schwartz, E | 1 |
| Pillari, V | 1 |
| Peterson, RE | 1 |
| Leijon, I | 1 |
| Billström, G | 1 |
| Lind, I | 1 |
| Bissenden, JG | 1 |
| Scott, PH | 1 |
| Hallum, J | 1 |
| Mansfield, HN | 1 |
| Scott, P | 1 |
| Wharton, BA | 1 |
| Kaneoka, T | 1 |
| Aso, M | 1 |
| Nobori, M | 1 |
| Aonuma, M | 1 |
| Shimizu, H | 1 |
| Shirakawa, K | 1 |
| Tayama, C | 1 |
| Ichimaru, S | 1 |
| Ito, M | 1 |
| Nakayana, M | 1 |
| Maeyama, M | 1 |
| Miyakawa, I | 1 |
| Varma, TR | 1 |
| Bianchi, R | 2 |
| Martorell, R | 1 |
| Kirssinger, C | 1 |
| Díaz, L | 1 |
| Ortiz, M | 1 |
| Hahn, L | 1 |
| Concha Garretón, J | 1 |
| Miranda Venegas, C | 1 |
| Leader, LR | 1 |
| Woods, DL | 1 |
| Pavelka, R | 1 |
| Schmid, R | 1 |
| Reinold, E | 1 |
| Briët, JW | 1 |
| Hoorn, RK | 1 |
| Bacigalupo, G | 1 |
| Saling, EZ | 1 |
| Gesche, J | 1 |
| Valderrama, O | 1 |
| Devoto, L | 1 |
| Herrera, M | 1 |
| Castro, O | 1 |
| Kohen, P | 1 |
| Nielsen, PV | 2 |
| Schiøler, V | 1 |
| Lieppman, RE | 1 |
| Williams, MA | 1 |
| Cheng, EY | 1 |
| Resta, R | 1 |
| Zingheim, R | 1 |
| Hickok, DE | 1 |
| Luthy, DA | 1 |
| Markestad, T | 1 |
| Bergsjø, P | 1 |
| Aakvaag, A | 1 |
| Lie, RT | 1 |
| Jacobsen, G | 2 |
| Hoffman, HJ | 1 |
| Bakketeig, LS | 1 |
| Kowalczyk, TD | 1 |
| Cabaniss, ML | 1 |
| Cusmano, L | 1 |
| Kaijser, M | 1 |
| Granath, F | 1 |
| Cnattingius, S | 1 |
| Ekbom, A | 1 |
| Tulchinsky, D | 1 |
| Weerasinghe, DS | 1 |
| Legge, M | 1 |
| Aickin, DR | 1 |
| Jarvis, GJ | 1 |
| MacDonald, HN | 1 |
| Drew, JH | 1 |
| Abell, DA | 1 |
| Beischer, NA | 2 |
| Westin, B | 1 |
| Shackleton, CH | 1 |
| Macrae, DJ | 2 |
| Willmott, MP | 2 |
| Oats, JJ | 1 |
| Arias, F | 1 |
| Lang, N | 1 |
| Bellmann, O | 1 |
| Hansmann, M | 1 |
| Nocke, W | 1 |
| Niesen, M | 1 |
| Granat, M | 1 |
| Sharf, M | 1 |
| Diengott, D | 1 |
| Spindel, A | 1 |
| Kahana, L | 1 |
| Elrad, H | 1 |
| Paci, S | 1 |
| Russo, G | 1 |
| Mure, G | 1 |
| Parisi, R | 1 |
| de Filippo, V | 1 |
| Correnti, R | 1 |
| Eliamo, A | 1 |
| Comis, B | 1 |
| Latagliata, C | 1 |
| Ventimiglia, E | 1 |
| Witter, FR | 1 |
| Weitz, CM | 1 |
| Woo, JS | 1 |
| Poon, IM | 1 |
| Palo, P | 1 |
| Erkkola, R | 1 |
| Irjala, K | 1 |
| Taina, E | 1 |
| Gerhard, I | 1 |
| Fitzer, C | 1 |
| Klinga, K | 1 |
| Rahman, N | 1 |
| Runnebaum, B | 1 |
| Schultz-Larsen, P | 1 |
| Schioeler, V | 1 |
| Mohamedally, SM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Early Prediction Of Preterm Delivery By Measurement Of Maternal Serum Markers[NCT01009723] | 2,000 participants (Anticipated) | Observational | 2010-03-31 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for estriol and Infant, Small for Gestational Age
| Article | Year |
|---|---|
Combinations of maternal serum markers to predict preeclampsia, small for gestational age, and stillbirth: a systematic review.
Topics: alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Estriol; Female; Gestational Age | 2012 |
Low birth weight babies. The small for gestational age. A review of current management.
Topics: Blood Volume; Estriol; Female; Fetal Growth Retardation; Fetus; Heart Rate; Humans; Infant, Low Birt | 1984 |
The diagnosis and management of intra-uterine growth retardation.
Topics: Delivery, Obstetric; Estriol; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Infant, Sma | 1980 |
Endocrine evaluation in the diagnosis of intrauterine growth retardation.
Topics: Dehydroepiandrosterone; Estriol; Female; Fetal Distress; Fetal Growth Retardation; Fetus; Growth; Hu | 1977 |
1 trial available for estriol and Infant, Small for Gestational Age
| Article | Year |
|---|---|
A randomized trial of induction at 42 weeks gestation versus expectant management for postdates pregnancies.
Topics: Cesarean Section; Clinical Trials as Topic; Costs and Cost Analysis; Creatinine; Estriol; Female; Hu | 1987 |
37 other studies available for estriol and Infant, Small for Gestational Age
| Article | Year |
|---|---|
The association of maternal serum biomarkers and birth weight in twin pregnancy: a retrospective cohort study.
Topics: Biomarkers; Birth Weight; Estriol; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Infant | 2022 |
Quad test for fetal aneuploidy screening as a predictor of small-for-gestational age fetuses: a population-based study.
Topics: Adolescent; Adult; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Down | 2020 |
Can quadruple test parameters predict SGA infants?
Topics: Adolescent; Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Estriol; Female; Humans; Infant, Newb | 2013 |
Abnormal analyte preeclampsia: do the second-trimester maternal serum analytes help differentiate preeclampsia subtypes?
Topics: Adult; alpha-Fetoproteins; Birth Weight; Chorionic Gonadotropin, beta Subunit, Human; Estriol; Femal | 2013 |
Double-positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes.
Topics: alpha-Fetoproteins; Case-Control Studies; Chorionic Gonadotropin; Chromosome Aberrations; Congenital | 2002 |
Cushing's syndrome in pregnancy.
Topics: Adenoma; Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adult; Blood Glucose; Cleft Palate; Cushi | 1982 |
An 18-month follow-up study of growth-retarded neonates. Relation to biochemical tests of placental function in late pregnancy and neurobehavioural condition in the newborn period.
Topics: Adolescent; Adult; Developmental Disabilities; Estriol; Female; Fetal Growth Retardation; Growth; Hu | 1980 |
Racial variations in tests of fetoplacental function.
Topics: Adult; alpha-Fetoproteins; Asian People; Cystinyl Aminopeptidase; Estriol; Female; Fetal Growth Reta | 1981 |
[Ultrasonic and biochemical detection and prenatal treatments of intra-uterine fetal growth retardation (author's transl)].
Topics: alpha-Fetoproteins; Estriol; False Negative Reactions; Female; Fetal Growth Retardation; Humans; Inf | 1980 |
Unconjugated estradiol, estriol and total estriol in maternal peripheral vein, cord vein, and cord artery serum at delivery in pregnancies with intrauterine growth retardation.
Topics: Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estriol; Female; Fetal Blood; Fet | 1983 |
[Fetal growth retardation. 1983 experience at the Hospital Paula Jaraquemada].
Topics: Apgar Score; Congenital Abnormalities; Estriol; Female; Fetal Growth Retardation; Gestational Age; H | 1984 |
Estriol screening in pregnancy.
Topics: Estriol; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Small for Gestational A | 1983 |
[Urinary estriol in high-risk pregnancies. Bibliographic and clinical review].
Topics: Adolescent; Adult; Estriol; Female; Fetal Death; Humans; Infant, Newborn; Infant, Small for Gestatio | 1981 |
Evaluation of various monitoring techniques in late pregnancy to detect poor intrauterine fetal growth.
Topics: Electrocardiography; Estriol; Female; Fetal Heart; Fetal Monitoring; Heart Rate; Humans; Infant, New | 1982 |
The use of human placental lactogen, oxytocinase and estriol in twin pregnancies with intrauterine growth retardation.
Topics: Aminopeptidases; Cystinyl Aminopeptidase; Estriol; Female; Fetal Growth Retardation; Humans; Infant, | 1982 |
Paired measurements of total and unconjugated estriol in maternal plasma during the 2nd and 3rd trimester of pregnancy - their relationship to intrauterine growth retardation.
Topics: Adult; Estriol; Female; Fetal Growth Retardation; Fetal Monitoring; Humans; Infant, Newborn; Infant, | 1982 |
[Plasma estriol curve using radioimmunoassay in normal pregnancy].
Topics: Birth Weight; Estriol; Female; Fetal Growth Retardation; Gestational Age; Humans; Infant, Newborn; I | 1982 |
Ratio of human placental lactogenic hormone (hPL) in amniotic fluid/maternal serum.
Topics: Amniotic Fluid; Estriol; Female; Fetal Growth Retardation; Humans; Infant, Low Birth Weight; Infant, | 1981 |
An association between elevated levels of human chorionic gonadotropin in the midtrimester and adverse pregnancy outcome.
Topics: Chorionic Gonadotropin; Cohort Studies; Estriol; Female; Humans; Infant, Low Birth Weight; Infant, N | 1993 |
Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol.
Topics: Adult; Case-Control Studies; Chorionic Gonadotropin; Embryonic and Fetal Development; Estriol; Femal | 1997 |
Association of low unconjugated estriol in the second trimester and adverse pregnancy outcome.
Topics: Adult; Biomarkers; Estriol; Female; Fetal Growth Retardation; Humans; Infant, Small for Gestational | 1998 |
Maternal pregnancy estriol levels in relation to anamnestic and fetal anthropometric data.
Topics: Birth Weight; Estriol; Female; Humans; Infant, Newborn; Infant, Small for Gestational Age; Maternal | 2000 |
The clinical significance of low urine oestriol values.
Topics: Estriol; Female; Fetal Death; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Small for | 1977 |
Fetal movements in small-for-dates babies.
Topics: Adult; Estriol; Female; Fetal Death; Fetal Growth Retardation; Fetus; Humans; Infant, Newborn; Infan | 1979 |
Congenital malformations, abnormal glucose tolerance, and estriol excretion in pregnancy.
Topics: Australia; Congenital Abnormalities; Estriol; Female; Fetal Death; Glucose Tolerance Test; Humans; H | 1978 |
Gravidogram and fetal growth. Comparison with biochemical supervision.
Topics: Apgar Score; Body Weight; Estriol; Female; Fetal Death; Fetal Growth Retardation; Fetus; Humans; Inf | 1977 |
Comparison of oestriol in mother and fetus during labour and in the baby at birth.
Topics: Birth Weight; Chromatography, Gas; Estriol; Female; Fetal Blood; Humans; Infant, Newborn; Infant, Sm | 1978 |
The recurrence rate and significance of low oestriol excretion in successive pregnancies.
Topics: Estriol; Female; Fetal Death; Fetal Growth Retardation; Humans; Infant, Newborn; Infant, Newborn, Di | 1979 |
The diagnosis and management of intrauterine growth retardation.
Topics: Cephalometry; Estriol; Female; Fetal Diseases; Growth Disorders; Humans; Infant, Low Birth Weight; I | 1977 |
[Clinical aspects and diagnosis of intrauterine growth retardation].
Topics: Adult; Estriol; Female; Fetus; Germany, West; Gestational Age; Humans; Infant Mortality; Infant, Low | 1977 |
Further investigation on the predictive value of human placental lactogen in high-risk pregnancies.
Topics: Adult; Estriol; Female; Fetal Growth Retardation; Humans; Hypertension; Infant, Newborn; Infant, Sma | 1977 |
[Usefulness and limitations of hormonal monitoring of pregnancy with HPL and estriol in improving fetal prognosis and preventing neonatal neurologic deficiency].
Topics: Adolescent; Adult; Child, Preschool; Developmental Disabilities; Estriol; Female; Fetal Growth Retar | 1989 |
Re-defining the role of oestriol measurements in antepartum fetal surveillance.
Topics: Estriol; Female; Fetal Growth Retardation; Fetal Monitoring; Humans; Infant, Newborn; Infant, Small | 1986 |
Serum free estriol inefficient in the detection of intrauterine growth retardation.
Topics: Estriol; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Infant, Small for Gestational Ag | 1987 |
Estrogen screening in evaluation of fetal outcome and infant's development.
Topics: Apgar Score; Birth Weight; Child Development; Estriol; Estrogens; Female; Fetal Monitoring; Humans; | 1986 |
Screening in pregnancy with unconjugated estriol compared with total estriol.
Topics: Adult; Apgar Score; Birth Weight; Estriol; Female; Fetal Death; Fetal Diseases; Fetal Distress; Feta | 1985 |
Clinical and endocrinological effects of intermittent abdominal decompression in complications of pregnancy.
Topics: Abdomen; Decompression; Estriol; Female; Humans; Hypertension; Infant, Small for Gestational Age; Lo | 1972 |